Pictet-Biotech-P USD Logo

Pictet-Biotech-P USD (PBF)

XHAN

Currency in EUR
1,376.01
-42.27 (-2.98%)

Closed

Aug 21, 2026

Day's Range

1,376.01
1,376.01

52 wk Range

813.48
1,433.26

Profile - PBF - Pictet-Biotech-P USD

Profile

Mic Code

XHAN

Employees

0


Pictet-Biotech-P USD is an investment fund that focuses on the biotechnology sector. Its primary function is to provide investors with growth opportunities by actively managing a portfolio of companies engaged in the development, production, and marketing of biotechnological innovations. This fund specifically targets advancements within healthcare, pharmaceuticals, and life sciences, sectors known for their rapid technological development and potential for significant impact on public health. Notable features of Pictet-Biotech-P USD include its diversified exposure to various biotech companies ranging from emerging startups to established industry leaders. This diversification helps mitigate risk while allowing investors to capitalize on breakthroughs in areas like genetic engineering, molecular biology, and biomedical research. The fund plays a critical role in the financial market by providing capital to pioneering enterprises that drive innovation in drug development, diagnostic tools, and therapeutic solutions. Pictet-Biotech-P USD stands out for its strategic focus on fostering advancements that could lead to new treatments and healthcare solutions, reflecting the growing market significance of biotechnology in addressing global health challenges.

Profile Details

Type

Mutual Fund

Country

Germany

Cross Listings - PBF - Pictet-Biotech-P USD

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Funds news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.